Implant detachment with thermal activation

Information

  • Patent Grant
  • 11051822
  • Patent Number
    11,051,822
  • Date Filed
    Thursday, June 1, 2017
    6 years ago
  • Date Issued
    Tuesday, July 6, 2021
    2 years ago
Abstract
Treatment of an aneurysm or other vascular defect can be facilitated or enhanced by an implant delivered with a thermally activated detachment system. A delivery system can include an implant with a proximal portion that defines a port. A pusher device can include arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the implant. The arms can, at a certain temperature, transition from engagement with the implant to a shape that facilitates release of the implant. Additionally or alternatively, a coil can engage an outer surface of the implant at the proximal portion and transition to a shape that facilitates release of the implant.
Description
FIELD

The subject technology relates to the delivery of implantable medical devices and systems for delivering implantable medical devices.


BACKGROUND

The use of endovascular techniques for the implantation of medical devices for treatment, e.g., by occlusion, of body cavities such as arteries, veins, fallopian tubes or vascular deformities is known in the art. For example, vascular aneurysms can be occluded with an implant that is introduced with a pusher member through a catheter. Once advanced to the treatment site, the implant is inserted into the aneurysm cavity to occlude the aneurysm and then detached from the pusher member.


SUMMARY

Detachment of an implant from the pusher member can be problematic. It is essential that the implant form as small a profile as possible to be guided through the fine bore of a catheter and it must be configured to bring about a reliable severance of the implant from the pusher member. Absent a reliable severance of the implant, withdrawal of the pusher member and catheter may cause unintended removal of the implant from the aneurysm or vessel to be occluded, and thus injure and/or rupture of the wall of the aneurysm or vessel.


A thermally activated detachment mechanism can be employed for controllably releasing an implantable medical device from a delivery connection assembly in a reliable, rapid, and accurate manner. Thermally activated detachment mechanisms can have advantages compared to electrolytic detachment systems. For example, severance of implantable medical devices can involve engagement and disengagement by a delivery connection assembly that minimizes a protruding aspect of the medical devices at an engagement region thereof. The delivery connection assembly can be designed to engage the medical device such that, after disengagement, the mechanisms for engagement are removed with the delivery connection assembly. Such an arrangement can facilitate rapid severance and leave a medical device without an end that protrudes as far as would an implant's connection to an electrolytic detachment junction after detachment.


In contrast, electrolytic detachment of an implant can leave a portion of the delivery wire protruding from the implant after detachment, presenting a risk of harm to the surrounding anatomy. Additionally, electrolytic detachment can leave behind debris, such as small particulate matter, that can interfere with MRI imaging during a procedure.


Thermally activated detachment mechanisms also can have advantages compared to mechanical detachment systems. For example, while some mechanical methods for the severance of implants from delivery systems are reliable, mechanical energy must be transmitted (e.g., by rotation of the delivery wire), which may cause the implant to be dislodged out of the correct position. A thermally activated detachment system can avoid the need for transmission of mechanical energy.


The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology.


Clause 1. A delivery system, comprising:

    • an implant comprising (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension; and
    • a pusher device comprising arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity, the arms having a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension, the arms having a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension, and the arms being configured to transition from the first configuration to the second configuration when above a transition temperature.


Clause 2. The delivery system of clause 1, wherein each of the arms comprises a longitudinal section extending from the junction to the distal section.


Clause 3. The delivery system of any one of clauses 1-2, wherein the distal sections extend radially outwardly.


Clause 4. The delivery system of any one of clauses 1-3, wherein the distal sections define a maximum outer cross-sectional dimension of a distal region of the pusher device.


Clause 5. The delivery system of any one of clauses 1-4, wherein the arms are of a shape memory material.


Clause 6. The delivery system of any one of clauses 1-5, further comprising a heating element thermally connected to the pusher device.


Clause 7. The delivery system of any one of clauses 1-6, further comprising an electrical circuit thermally connected to the pusher device.


Clause 8. The delivery system of any one of clauses 1-7, wherein the proximal portion of the implant is a circumferentially continuous hub.


Clause 9. The delivery system of any one of clauses 1-8, wherein the proximal portion of the implant is a helical coil.


Clause 10. A method of delivering an implant, the method comprising:

    • positioning the implant at a target location within a patient while the implant is attached to a pusher device, wherein the implant comprises (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension, wherein the pusher device comprises arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity; and
    • releasing the implant from the pusher device by increasing a temperature of the arms, such that the arms transition from (i) a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension to (ii) a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension.


Clause 11. The method of clause 10, wherein the releasing comprises operating a heating element thermally connected to the pusher device.


Clause 12. The method of any one of clauses 10-11, wherein the releasing comprises conducting an electrical current through the pusher device.


Clause 13. The method of any one of clauses 10-12, wherein the releasing comprises retracting the distal sections of the arms proximally from the cavity through the port.


Clause 14. The method of clause 13, wherein the releasing further comprises, while retracting the distal sections of the arms, stabilizing the implant with a catheter housing at least a portion of the pusher device.


Clause 15. The method of any one of clauses 10-14, wherein the releasing comprises articulating the arms with respect to the junction.


Clause 16. A delivery system, comprising:

    • an implant comprising a proximal portion that defines an outer cross-sectional dimension; and
    • a pusher device comprising a coil extending helically about the proximal portion;
    • wherein the coil has a first configuration in which the coil is biased to form a lumen with a first inner cross-sectional dimension, smaller than the outer cross-sectional dimension of the proximal portion;
    • wherein the coil has a second configuration in which the lumen of the coil has a second inner cross-sectional dimension, larger than the outer cross-sectional dimension of the proximal portion;
    • wherein the coil is configured to transition from the first configuration to the second configuration when above a transition temperature.


Clause 17. The delivery system of clause 16, wherein at least a portion of the coil extends distally of an entire length of the proximal portion.


Clause 18. The delivery system of any one of clauses 16-17, wherein the coil is of a shape memory material.


Clause 19. The delivery system of any one of clauses 16-18, further comprising a heating element thermally connected to the pusher device.


Clause 20. The delivery system of any one of clauses 16-19, further comprising an electrical circuit thermally connected to the pusher device.


Clause 21. The delivery system of any one of clauses 16-20, wherein the proximal portion of the implant is a circumferentially continuous hub.


Clause 22. A method of delivering an implant, the method comprising:

    • positioning the implant at a target location within a patient while the implant is attached to a pusher device, wherein the implant comprises a proximal portion that defines an outer cross-sectional dimension, wherein the pusher device comprises a coil extending helically about the proximal portion; and
    • releasing the implant from the pusher device by increasing a temperature of the coil, such that the coil transitions from (i) a first configuration in which the coil is biased to form a lumen with a first inner cross-sectional dimension, smaller than the outer cross-sectional dimension of the proximal portion to (ii) a second configuration in which the lumen of the coil has a second inner cross-sectional dimension, larger than the outer cross-sectional dimension of the proximal portion.


Clause 23. The method of clause 22, wherein the releasing comprises operating a heating element thermally connected to the pusher device.


Clause 24. The method of any one of clauses 22-23, wherein the releasing comprises conducting an electrical current through the coil.


Clause 25. The method of any one of clauses 22-24, wherein the releasing comprises retracting the coil proximally from the implant.


Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.


It is to be understood that both the foregoing general description and the following detailed description are exemplifying and explanatory and are intended to provide further explanation of the subject technology as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this description, illustrate aspects of the subject technology and, together with the specification, serve to explain principles of the subject technology.



FIG. 1A shows a plan view of a delivery system in accordance with some embodiments of the subject technology.



FIG. 1B shows an enlarged view of a distal portion of FIG. 1A, in accordance with one or more embodiments of the present disclosure.



FIG. 2A shows a perspective side view of a braid ball implant, in accordance with one or more embodiments of the subject technology.



FIG. 2B shows a sectional view of the braid ball implant of FIG. 2B, in accordance with one or more embodiments of the subject technology.



FIG. 3 shows in partial cross-section a portion of the delivery system and the braid ball implant of FIGS. 2A-2B, in accordance with some embodiments of the subject technology.



FIG. 4 shows a partial sectional view of a distal end of the delivery system of FIG. 1A connected to a proximal portion of the braid ball implant of FIGS. 2A-2B, in accordance with one or more embodiments of the subject technology.



FIG. 5A shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4, in accordance with one or more embodiments of the present disclosure.



FIG. 5B shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4, in accordance with one or more embodiments of the present disclosure.



FIG. 5C shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4, in accordance with one or more embodiments of the present disclosure.



FIG. 6 shows a partial sectional view of a distal end of a delivery system and a proximal portion of a coil implant, in accordance with one or more embodiments of the subject technology.



FIG. 7 shows a view of a delivery system in partial cross-section and the braid ball implant of FIGS. 2A-2B, in accordance with some embodiments of the subject technology.



FIG. 8A shows a side view of a distal end of a delivery system and a proximal portion of an implant, in accordance with one or more embodiments of the subject technology.



FIG. 8B shows a partial sectional view of the distal end of the delivery system and proximal portion of the implant of FIG. 8A, in accordance with one or more embodiments of the subject technology.



FIG. 9A shows a sectional view of the distal end of the delivery system and the proximal portion of the implant of FIG. 8A, in accordance with one or more embodiments of the present disclosure.



FIG. 9B shows a sectional view of the distal end of the delivery system and the proximal portion of the implant of FIG. 8A, in accordance with one or more embodiments of the present disclosure.





DETAILED DESCRIPTION

The detailed description set forth below is intended as a description of various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology may be practiced. The appended drawings are incorporated herein and constitute a part of the detailed description. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. However, the subject technology may be practiced without these specific details. In some instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology.


An implantable medical device, e.g., a vascular implant, may be positioned using a delivery system 10 such as, for example, the one shown in FIGS. 1A-1B. As illustrated in FIGS. 1A-1B for example, the delivery system 10 can include an actuator 20, a positioner 40 coupled with the actuator 20, and a delivery connection assembly (not shown) extending from the actuator 20 and within the positioner 40. A portion of a delivery system 10 may engage a complementary portion of an implant 95 in order to control the delivery and detachment of the implant 95 at the desired location.


A power supply 70 can be coupled to a proximal portion of the positioner 40, for example at the actuator 20. A current can flow from the power supply 70 along a first lead 72 to a location near the implant 95 and along a second lead 74 from the location near the implant 95 to the power supply 70. The power supply 70 may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current. A positive terminal of the power supply 70, for example as shown in FIG. 1A, may be coupled to the first lead 72, and a negative terminal of the power supply 70 may be coupled to the second lead 74. The power supply 70 may provide a current through the delivery system 10 to initiate a heating process during use of the delivery system 10 to release the implant 95, as discussed further herein. According to some embodiments, the power supply 70 can include an electrical generator configured to output an electrical current that is sufficient to actuate the delivery system 10 to release the implant 95. The power supply 70 can include a suitable controller that can be used to control various parameters of the energy output by the generator, such as intensity, amplitude, duration, frequency, duty cycle, and polarity.


According to some embodiments, for example as shown in FIGS. 2A-2B, an implant 95 delivered by the delivery system 10 can be or include a braid ball 92. While the implant 95 is shown or described in several embodiments as comprising a braid ball 92, any implant or device that is compatible with the subject technology may be used in lieu of or in conjunction with the example implant 95 disclosed herein, in accordance with the embodiments described herein. Suitable implants and devices include, but are not limited to, stents, filters, thrombectomy devices, atherectomy devices, flow restoration devices, embolic coils, spherical devices, embolic protection devices, or other well-known treatment devices.


The braid ball 92 can be formed from tubular braid stock including a resilient material, such as nitinol, that defines an open volume in an uncompressed/unconstrained state. The size of the implant can be selected to fill an aneurysm when expanded therein. The implant 95 can include a hub 50 and layers 26, 28. The hub can be located at a proximal portion 53 of the implant. The hub 50 can be fixedly attached to the remainder of the implant 95. For example, the hub 50 can grasp braided filaments of the layers 26, 28 of the implant 95. The implant 95 can include the layers 26, 28 at least where impacted by flow at a neck of the aneurysm.


According to some embodiments, the hub 50 can be fixedly attached to the remainder of the implant 95. For example, the hub 50 can grasp braided filaments of the layers 26, 28 of the implant 95. A port 54 can be provided within the hub 50. The port 54 can define a port inner cross-sectional dimension 58. The port inner cross-sectional dimension 58 can be a minimum or maximum inner cross-sectional dimension within a region of the proximal portion 53. For example, a region distal to the hub 50 can include a cavity 96 that defines an inner cross-sectional dimension 98 that is greater than the port inner cross-sectional dimension 58. The hub 50 can further define a hub outer cross-sectional dimension 59. The hub outer cross-sectional dimension 59 can be a minimum or maximum outer cross-sectional dimension within a region of the proximal portion 53. For example, a region distal to the hub 50 can define an outer cross-sectional dimension 57 that is smaller than the hub outer cross-sectional dimension 59. The port 54 or an outer surface of the hub 50 can accept the implant 95. Delivery system construction and further optional details of the implant 95 are provided below. FIG. 3 shows the braid ball 92 attached to a distal end 22 of the delivery system 10, and positioned within an aneurysm 16. The delivery system 10 extends proximally from the implant 95 to a location outside of the body where the delivery system can be manipulated by a user. As illustrated in FIG. 3, the delivery system 10 can comprise a microcatheter 14 and a delivery connection assembly that includes the positioner 40. The microcatheter 14 is advanced until its distal end is in the vicinity of a target site, such as the aneurysm 16, for example as shown in FIG. 3. The positioner 40 is advanced within the microcatheter 14 to access the target site. The positioner 40 can be advanced out of the microcatheter 14 and directed to the target site. The implant 95 can be advanced with the positioner 40 until the implant 95 is positioned at the target site.


The delivery system 10 and the microcatheter 14 can have lengths sufficient to extend from outside the patient's body to a target location in the brain. For example, each of them can be at least 125 cm long, and more particularly may be between about 125 cm and about 175 cm long, with the delivery system 10 being longer than the microcatheter 14. Typically the microcatheter 14 is about 155 cm long. Commercially available microcatheters which may be suitable for use as delivery catheters include the REBAR™ Reinforced Micro Catheter, which is available from Medtronic, Inc. and the MARKSMAN™ Catheter, which is available from Medtronic, Inc.


When the delivery system 10 has been advanced to a target aneurysm 16, the implant 95 can be inserted within the aneurysm 16 and expanded to a fully deployed state, for example as illustrated in FIG. 3. The position of the implant 95 can be affected and/or modified by corresponding motion of the delivery system 10. A radiopaque marker (e.g., the hub 50) of the implant 95 can be utilized to track and confirm delivery of the implant 95 to the target location.


According to some embodiments, the implant 95 is supported during delivery by a delivery connection assembly 12, from which the implant 95 can also be detached. According to some embodiments, for example as shown in FIG. 4, the delivery connection assembly 12 can include the positioner 40, a pusher device 78 and a heating element 76. The pusher device 78 can include one or more arms 82 that engage the implant 95. The heating element 76 can controllably provide heat to the pusher device 78 to actuate the arms until the arms 82 released the implant 95.


According to some embodiments, the pusher device 78 can include one or more arms 82 extending distally from a junction 80 of the pusher device 78 and through the port 54. One or more of the arms 82 can include a distal section 84 that can be positioned distal to at least a portion of the port 54 and/or within a cavity 96 of the implant 95. According to some embodiments, the arms 82 can extend longitudinally from the junction 80, and the distal sections 84 can extend radially outwardly from the arms 82. In at least one configuration, the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the port inner cross-sectional dimension 58. Accordingly, passage of the distal sections 84 proximally through the port 54 is resisted until the distal sections 84 are transitioned to a different configuration.


According to some embodiments, the arms 82 are configured to flex, bend, pivot, or articulate with respect to the junction 80 in response to temperature changes. Such action can be achieved based on a programmed characteristic of the arms 82. When the arms 82 are at or above a transition temperature, the arms 82 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which the arms 82 in a relaxed state can disengage from the implant 95, as will be more fully described herein.


The transition temperature at which the arms 82 begin to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature. The transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in the arms 82 by an application of heat other than from the body. Exemplifying materials for use in the composition of the junction 80 and/or the arms 82 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof. Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE).


According to some embodiments, for example as shown in FIG. 4, a heating element 76 can be provided in thermal connection with the junction 80 and the arms 82. The heating element 76 can be connected to the power supply 70 via the first and second leads 72, 74 to direct a current through the heating element 76. The leads 72, 74 can extend alongside the pusher device 78 within a lumen of the positioner 40 and proximally from the heating element 76 to outside the patient's body.


At least a portion of the heating element 76 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied. The heating element 76 can include a number of coil windings about a portion of the pusher device 78, for example as illustrated in FIG. 4. The heating element 76 can contact or be in close proximity to one or more of the junction 80 and the arms 82. For example, the heating element 76 can be adjacent to or overlap with one or more of the junction 80 and the arms 82. Heat generated by the heating element 76 can be conducted to achieve an increase in temperature along one or more portions of the pusher device 78. Alternatively or in combination, the heating element 76 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light. Alternatively or in combination, the arms 82 and/or the junction 80 may serve as a heating element by directing an electrical current therethrough.



FIGS. 5A-5C illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology. FIG. 5A illustrates the delivery connection assembly 12 and implant 95 of FIG. 4 with the hub 50 of the implant held between the pusher device 78 and the positioner 40. FIG. 5B illustrates a stage of detachment in progress. FIG. 5C illustrates the implant 95 detached from the delivery system 10.


According to some embodiments, the implant 95 can be positioned with the positioner 40 and the pusher device 78. Distally directed forces can be transmitted from the positioner 40 to the hub 50 of the implant 95. Additionally, proximally directed forces can be transmitted from the pusher device 78 to the hub 50 of the implant 95.


According to some embodiments, for example as shown in FIGS. 5A and 5B, a transition of the arms 82 can be achieved to facilitate removal of the arms 82 from engagement with the implant 95. The transition can be achieved as described herein, for example by applying heat to the arms 82 and/or the junction 80. As a result of the transition, the distal sections 84 can transition (e.g., move inwardly as illustrated in FIGS. 5A and 5B) from the maximum outer cross-sectional dimension 86 to a second maximum outer cross-sectional dimension 88 that is smaller than the port inner cross-sectional dimension 58.


According to some embodiments, for example as shown in FIGS. 5B and 5C, the transition of the arms 82 (e.g., inward movement of the arms 82) can allow the arms 82 to completely disengage from the implant 95. For example, the arms 82 can move proximally through the port 54 such that the distal sections 84 are entirely proximal of the implant 95. During proximal retraction of the pusher device 78, the positioner 40 can stabilize the implant 95, for example by applying a distally directed force while the positioner 40 contacts the hub 50. Upon full disengagement by the pusher device 78, the pusher device 78, the positioner 40, the microcatheter 14 (if employed), and/or a guide catheter 13 (if employed) can be retracted away from the target implant site and out of the patient, leaving the implant 95 at the target implant site.


Although FIGS. 4-5C illustrate an implant 95 comprising a braid ball 92, the delivery system 10 can be used with a coil implant 90, for example as illustrated in part in FIG. 6, according to one or more embodiments of the subject technology. Therefore, the positioner 40 and other elements and components of the delivery system 10 are neither illustrated in FIG. 6 nor described again in detail with reference to FIG. 6, as these components can be readily understood from the other disclosure of them herein.


According to some embodiments, for example as shown in FIG. 6, the pusher device 78 can be configured to engage a coil implant 90. The coil implant 90 can include a proximal portion 102 and a distal portion 104. The proximal portion 102 can be smaller than the distal portion 104 and reside at least partially within a cavity 196 of the distal portion 104, such that the proximal portion 102 and the distal portion 104 at least partially overlap. The proximal portion 102 and the distal portion 104 can form separate portions of a continuous helical coil. Alternatively, the proximal portion 102 and the distal portion 104 can be separate structures that are joined together by an intervening structure. Although FIG. 6 illustrates the proximal portion 102 and the distal portion 104 as coils, the proximal portion 102 and/or the distal portion 104 can also form another circumferentially continuous structure, such as a cylindrical tube as an alternative to a helical coil or in combination with a helical coil.


The proximal portion 102 can be disposed at the proximal end of the distal portion 104 and can further define a port 154. The port 154 can extend completely through the proximal portion 102. The port 154 can be large enough to receive the arms 82 of the pusher device 78. The port 154 can define a port inner cross-sectional dimension 158. The port inner cross-sectional dimension 158 can be a minimum or maximum inner cross-sectional dimension within a region of the proximal portion 102. For example, a region distal to the proximal portion 102 can include a cavity 196 that defines an inner cross-sectional dimension 198 that is greater than the port inner cross-sectional dimension 158.


According to some embodiments, for example as shown in FIG. 6, one or more of the distal sections 84 can be positioned distal to at least a portion of the port 154 and/or within the cavity 196 of the coil implant 90. In at least one configuration, the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the port inner cross-sectional dimension 158. According to some embodiments, for example as shown in FIG. 6, the distal sections 84 can extend into one or more gaps between windings of the distal portion 104 of the coil implant 90. For example, the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the inner cross-sectional dimension 198 of the distal portion 104. Accordingly, passage of the distal sections 84 proximally through the port 154 is resisted until the distal sections 84 are transitioned to a different configuration.


Although FIGS. 3-6 illustrate the delivery system 10 engaging the implant 95 within a cavity thereof, a delivery system 110 can be used to engage an outer portion of the implant 95, for example as illustrated in part in FIG. 7, according to one or more embodiments of the subject technology. Referring now to FIG. 7, the implant 95 can be attached to a distal end 121 of the delivery system 110, and positioned within an aneurysm 16. As illustrated in FIG. 7, the delivery system 110 can comprise a microcatheter 14 and a delivery connection assembly that includes the positioner 140. The microcatheter 14 is advanced until its distal end is in the vicinity of a target site, such as the aneurysm 16, for example as shown in FIG. 7. The positioner 140 is advanced within the catheter 14 to access the target site.



FIG. 8A shows an enlarged view of the distal end 121 of the delivery system 110 and a proximal portion of the implant 95 of FIG. 7. FIG. 8B shows a partial sectional view of the distal end 121 of the delivery system 110 and the proximal portion of the implant 95 shown in FIG. 8. FIGS. 8A and 8B show the implant 95 supported during delivery by a delivery connection assembly 122, from which the implant 95 can also be detached. The delivery connection assembly 122 can include fewer components than the delivery connection assembly 12, described above. According to some embodiments, for example as shown in FIGS. 8A and 8B, the delivery connection assembly 122 can include the positioner 140 and one or more coils 182 extending helically and distally from a pusher section 180 of the positioner 140.


The coil 182 can be positioned to extend about an outer periphery of a portion of the implant 95. For example, the coil 182 can wrap up around and engage the hub 50 of the implant 95. The coil 182 can extend proximal to the hub 50, along a length of the hub 50, and/or distal to the hub 50. For example, the coil 182 can extend to regions on one or both sides of the hub 50. A distalmost region of the coil 182 can engage a distal end of the hub 50. A proximalmost region of the coil 182 can engage a proximal end of the hub 50. Alternatively, a separate structure of the delivery connection assembly 122, e.g., a stop, can engage a proximal end of the hub 50.


The coil 182 can be affixed to the pusher section 180 of the positioner 140, such that movement of the pusher section 180 substantially transmit forces to the coil 182 and the implant 95. In at least one configuration, the coil 182 can be biased to form an inner cross-sectional dimension 188 that is smaller than the hub outer cross-sectional dimension 59. The bias of the coil 182 can refer to the tendency of the coil 182, in a relaxed configuration, to naturally move to a shape in which it forms the inner cross-sectional dimension 188. Despite this bias, the coil 182 may be prevented from completely achieving the shape of the relaxed configuration and instead engage the hub 50. While engaged on the hub 50, at least a portion of the coil 182 may have an inner cross-sectional dimension 188 that is equal to the hub outer cross-sectional dimension 59 of the hub 50. The bias can provide a force of engagement with the hub 50. Accordingly, movement of the hub 50 is limited or resisted until the coil 182 is transitioned to a different configuration.


According to some embodiments, the coil 182 is configured to flex, bend, unwind, and/or radially expand. Such action can be achieved based on a programmed characteristic of the coil 182. When the coil 182 is at or above a transition temperature, the coil 182 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which the coil 182 in a relaxed state can disengage from the implant 95, as will be more fully described herein.


The transition temperature at which the coil 182 begins to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature. The transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in the coil 182 by an application of heat other than from the patient's body. Exemplifying materials for use in the composition of the coil 182 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof. Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE).


According to some embodiments, for example as shown in FIG. 8B, a heating element 176 can be provided in thermal connection with the pusher section 180 and the coil 182. The heating element 176 can be connected to the power supply 70 via the first and second leads 172, 174 to direct a current through the heating element 176. The leads 172, 174 can extend within a lumen of the positioner 140 and proximally from the heating element 176 to outside the patient's body.


At least a portion of the heating element 176 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied. The heating element 176 can include a number of coil windings within a portion of the positioner 140, for example as illustrated in FIG. 8B. The heating element 176 can contact or be in close proximity to one or more of the pusher section 180 and the coil 182. For example, the heating element 176 can be adjacent to or overlap with one or more of the pusher section 180 and the coil 182. Heat generated by the heating element 176 can be conducted to achieve an increase in temperature along one or more portions of the positioner 140. Alternatively or in combination, the heating element 176 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light. Alternatively or in combination, the coil 182 and/or the pusher section 180 may serve as a heating element by directing an electrical current therethrough.


While the coil 182 can be a single filament helical winding, as shown in FIGS. 8A and 8B, other shapes for engaging the implant 95 are contemplated. According to some embodiments, the coil 182 can include multiple filaments that are the same or different sizes. The filaments can be wound in the same direction or counter wound. The filaments can be provided in a single layer or in multiple concentric layers. Alternatively or in combination, other shapes can be used to engage the implant 95, such as a circumferentially continuous structure, such as a cylindrical tube.



FIGS. 9A and 9B illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology. FIG. 9B illustrates the delivery connection assembly 122 and implant 95 of FIG. 8B with the hub 50 of the implant 95 held within the coil 182. FIG. 9B illustrates a stage of detachment in progress. FIG. 9B illustrates the implant 95 detached from the delivery connection assembly 122.


According to some embodiments, the implant 95 can be positioned with the delivery connection assembly 122. While the hub 50 is held within the coil 182, distally and/or proximally directed forces can be transmitted from the positioner 140 to the hub 50 of the implant 95. According to some embodiments, for example as shown in FIGS. 9A and 9B, a transition of the coil 182 can be achieved to facilitate removal of the coil 182 from engagement with the implant 95. The transition can be achieved as described herein, for example by applying heat to the coil 182 and/or the pusher section 180. As a result of the transition, the coil 182 can transition from (or from a bias toward) the inner cross-sectional dimension 188 to a second inner cross-sectional dimension 189 that is larger than the hub outer cross-sectional dimension 59 of the hub 50. The inner cross-sectional dimension 188 and the second inner cross-sectional dimension 189 can occur at the same region of the coil 182 at different stages of deployment.


According to some embodiments, for example as shown in FIGS. 9A and 9B, a transition of the coil 182 can allow the coil 182 to completely disengage from the implant 95. For example, the coil 182 can move proximally and entirely off of the hub 50. Upon full disengagement by the positioner 140, the positioner 140, the microcatheter 14, and/or the guide catheter 13 can be retracted away from the target implant site and out of the patient, leaving the implant 95 at the target implant site.


The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.


There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.


It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplifying approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.


A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as “an aspect” may refer to one or more aspects and vice versa. A phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such “an embodiment” may refer to one or more embodiments and vice versa. A phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as “a configuration” may refer to one or more configurations and vice versa.


Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.


A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.


While certain aspects and embodiments of the subject technology have been described, these have been presented by way of example only, and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the subject technology.

Claims
  • 1. A delivery system, comprising: an implant comprising (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension; anda pusher device comprising arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity, the arms having a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension, wherein, in the first configuration, the distal sections of the arms are movable in a distal direction relative to the port, the arms having a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension, and the arms being configured to transition from the first configuration to the second configuration when above a transition temperature.
  • 2. The delivery system of claim 1, wherein each of the arms comprises a longitudinal section extending from the junction to the distal section.
  • 3. The delivery system of claim 1, wherein the distal sections extend radially outwardly.
  • 4. The delivery system of claim 1, wherein the distal sections define a maximum outer cross-sectional dimension of a distal region of the pusher device.
  • 5. The delivery system of claim 1, wherein the arms are of a shape memory material.
  • 6. The delivery system of claim 1, further comprising a heating element thermally connected to the pusher device.
  • 7. The delivery system of claim 1, further comprising an electrical circuit thermally connected to the pusher device.
  • 8. The delivery system of claim 1, wherein the proximal portion of the implant is a circumferentially continuous hub.
  • 9. The delivery system of claim 1, wherein the proximal portion of the implant is a helical coil.
  • 10. The delivery system of claim 1, wherein the arms in the second configuration are curved toward one another.
  • 11. The delivery system of claim 1, wherein the arms comprise a first arm and a second arm, the first and second arms including respective first and second longitudinal sections each extending from the junction toward the distal section in a longitudinal direction, wherein, in the second configuration, the first and second longitudinal sections are spaced apart from one another in an axial direction, the axial direction being substantially orthogonal to the longitudinal direction.
  • 12. The delivery system of claim 1, wherein the arms comprise a first arm and a second arm, and wherein the first arm, second arm, and junction together comprise a continuous surface.
  • 13. The delivery system of claim 1, wherein the arms have a length spanning a majority of the arms, and wherein, in the first configuration, the arms are separated from one another by a substantially constant cross-sectional distance along the length.
  • 14. The delivery system of claim 1, wherein: the implant comprises a hub disposed over the proximal portion,in the first configuration, the distal sections of the arms are distal to the hub and movable in a distal direction relative to the port.
  • 15. A method of delivering an implant, the method comprising: positioning the implant at a target location within a patient while the implant is attached to a pusher device, wherein the implant comprises (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension, wherein the pusher device comprises arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity, wherein the distal sections are movable in a distal direction relative to the port; andreleasing the implant from the pusher device by increasing a temperature of the arms, such that the arms transition from (i) a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension to (ii) a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension.
  • 16. The method of claim 15, wherein the releasing comprises operating a heating element thermally connected to the pusher device.
  • 17. The method of claim 15, wherein the releasing comprises conducting an electrical current through the pusher device.
  • 18. The method of claim 15, wherein the releasing comprises retracting the distal sections of the arms proximally from the cavity through the port.
  • 19. The method of claim 18, wherein the releasing further comprises, while retracting the distal sections of the arms, stabilizing the implant with a catheter housing at least a portion of the pusher device.
  • 20. The method of claim 15, wherein the releasing comprises articulating the arms with respect to the junction.
  • 21. The method of claim 15, wherein the arms in the second configuration are curved toward one another.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority of U.S. Provisional Patent Application No. 62/355,431, filed Jun. 28, 2016, which is hereby incorporated by reference in its entirety.

US Referenced Citations (284)
Number Name Date Kind
5108407 Geremia et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5250071 Palermo Oct 1993 A
5354295 Guglielmi et al. Oct 1994 A
5370653 Cragg Dec 1994 A
5423829 Pham et al. Jun 1995 A
5509411 Littmann et al. Apr 1996 A
5522836 Palermo Jun 1996 A
5540680 Guqlielmi et al. Jul 1996 A
5578074 Mirigian Nov 1996 A
5624449 Pham et al. Apr 1997 A
5658308 Snyder Aug 1997 A
5669931 Cupiecki et al. Sep 1997 A
5690667 Gia Nov 1997 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5749894 Engelson May 1998 A
5766629 Cho et al. Jun 1998 A
5800455 Palermo et al. Sep 1998 A
5851206 Guglielmi et al. Dec 1998 A
5853418 Ken et al. Dec 1998 A
5855578 Guglielmi et al. Jan 1999 A
5891128 Gia et al. Apr 1999 A
5895385 Guqlielmi et al. Apr 1999 A
5916235 Guglielmi Jun 1999 A
5919187 Guqlielmi et al. Jul 1999 A
5925037 Guglielmi et al. Jul 1999 A
5925059 Palermo et al. Jul 1999 A
5928226 Guqlielmi et al. Jul 1999 A
5935145 Villar et al. Aug 1999 A
5941888 Wallace et al. Aug 1999 A
5944114 Guglielmi et al. Aug 1999 A
5947962 Guglielmi et al. Sep 1999 A
5947963 Guqlielmi Sep 1999 A
5951599 McCrory Sep 1999 A
5964797 Ho Oct 1999 A
5976126 Guglielmi Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
6010498 Guqlielmi Jan 2000 A
6013084 Ken et al. Jan 2000 A
6059779 Mills May 2000 A
6063070 Eder May 2000 A
6063104 Villar et al. May 2000 A
6066133 Guglielmi et al. May 2000 A
6077260 Wheelock et al. Jun 2000 A
6083220 Guglielmi et al. Jul 2000 A
6123714 Gia et al. Sep 2000 A
6136015 Kurz et al. Oct 2000 A
6146373 Cragg et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6165178 Bashiri et al. Dec 2000 A
6168592 Kupiecki et al. Jan 2001 B1
6168615 Ken et al. Jan 2001 B1
6168618 Frantzen Jan 2001 B1
6193728 Ken et al. Feb 2001 B1
6238403 Greene, Jr. et al. May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6280457 Wallace et al. Aug 2001 B1
6296622 Kurz et al. Oct 2001 B1
6299619 Greene, Jr. et al. Oct 2001 B1
6306153 Kurz et al. Oct 2001 B1
6309367 Boock Oct 2001 B1
6371972 Wallace et al. Apr 2002 B1
6409721 Wheelock et al. Jun 2002 B1
6416373 Kolb et al. Jul 2002 B1
6425893 GuQlielmi Jul 2002 B1
6425914 Wallace et al. Jul 2002 B1
6468266 Bashiri et al. Oct 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6478773 Gandhi et al. Nov 2002 B1
6485524 Strecker Nov 2002 B2
6486266 Amano et al. Nov 2002 B2
6511468 Craaa et al. Jan 2003 B1
6533801 Wallace et al. Mar 2003 B2
6558367 Craaa et al. May 2003 B1
6589230 Gia et al. Jul 2003 B2
6589236 Wheelock et al. Jul 2003 B2
6602261 Greene, Jr. et al. Aug 2003 B2
6605101 Schaefer et al. Aug 2003 B1
6620152 Guqlielmi Sep 2003 B2
6623493 Wallace et al. Sep 2003 B2
6723112 Ho et al. Apr 2004 B2
6743251 Eder Jun 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6878384 Cruise et al. Apr 2005 B2
6905503 Gifford Jun 2005 B2
6936055 Ken et al. Aug 2005 B1
6953473 Porter Oct 2005 B2
6964657 Craaa et al. Nov 2005 B2
6966892 Gandhi et al. Nov 2005 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7083567 Mawad Aug 2006 B2
7128736 Abrams et al. Oct 2006 B1
7166122 Aqanon et al. Jan 2007 B2
7169172 Levine et al. Jan 2007 B2
7198613 Gandhi et al. Apr 2007 B2
7229461 Chin et al. Jun 2007 B2
7238194 Monstadt et al. Jul 2007 B2
7255707 Ramzipoor et al. Aug 2007 B2
7300458 Henkes et al. Nov 2007 B2
7323000 Monstdt et al. Jan 2008 B2
7331974 Schaefer et al. Feb 2008 B2
7485122 Teoh Feb 2009 B2
7524322 Monstdt et al. Apr 2009 B2
7601160 Richter Oct 2009 B2
7608089 Wallace et al. Oct 2009 B2
RE41029 Guglielmi et al. Dec 2009 E
7651513 Teoh et al. Jan 2010 B2
7695484 Wallace et al. Apr 2010 B2
7879064 Monstadt et al. Feb 2011 B2
7896899 Patterson et al. Mar 2011 B2
7938845 Aganon et al. May 2011 B2
RE42625 Guglielmi Aug 2011 E
8002789 Ramzipoor et al. Aug 2011 B2
RE42756 Guqlielmi et al. Sep 2011 E
8016869 Nikolchev Sep 2011 B2
8021416 Abrams Sep 2011 B2
8043326 Hancock et al. Oct 2011 B2
8048104 Monstadt et al. Nov 2011 B2
RE43311 Wallace et al. Apr 2012 E
8157855 Eidenschink et al. Apr 2012 B2
8202292 Kellett Jun 2012 B2
8221396 Dehnad et al. Jul 2012 B2
8221483 Ford et al. Jul 2012 B2
8273116 Licata et al. Sep 2012 B2
8298256 Gandhi et al. Oct 2012 B2
8328860 Strauss et al. Dec 2012 B2
8372110 Monstadt et al. Feb 2013 B2
8398671 Chen et al. Mar 2013 B2
8425541 Masters et al. Apr 2013 B2
8470013 Duggal et al. Jun 2013 B2
8480701 Monstadt Jul 2013 B2
8562667 Cox Oct 2013 B2
8597321 Monstadt et al. Dec 2013 B2
8632584 Henkes et al. Jan 2014 B2
8641746 Andreas et al. Feb 2014 B2
8641777 Strauss et al. Feb 2014 B2
8652163 Padilla et al. Feb 2014 B2
8657870 Turovskiv et al. Feb 2014 B2
8715312 Burke et al. May 2014 B2
8715317 Janardhan et al. May 2014 B1
8721625 Klint May 2014 B2
8728142 Gandhi et al. May 2014 B2
8777978 Strauss et al. Jul 2014 B2
8777979 Shrivastava et al. Jul 2014 B2
8795320 Strauss et al. Aug 2014 B2
8795321 Strauss et al. Aug 2014 B2
8801747 Strauss et al. Aug 2014 B2
8845676 Monstadt et al. Sep 2014 B2
8864790 Strauss et al. Oct 2014 B2
8870909 Cox Oct 2014 B2
8876863 Eskridge Nov 2014 B2
8900285 Licata Dec 2014 B2
8906057 Connor et al. Dec 2014 B2
8915950 Cam et al. Dec 2014 B2
8926681 Levv et al. Jan 2015 B2
8932317 Marks et al. Jan 2015 B2
8940011 Teoh et al. Jan 2015 B2
8974509 Licata Mar 2015 B2
8974513 Ford et al. Mar 2015 B2
8992563 Chen Mar 2015 B2
8998926 Pomeranz Apr 2015 B2
9039749 Shrivastava et al. May 2015 B2
9050095 Monstadt et al. Jun 2015 B2
9055948 Jaeqer et al. Jun 2015 B2
9211202 Strother et al. Dec 2015 B2
9486224 Riina et al. Nov 2016 B2
9833309 Levi et al. Dec 2017 B2
9844380 Furey Dec 2017 B2
9907684 Connor et al. Mar 2018 B2
9962146 Hebert et al. May 2018 B2
10028745 Morsi Jul 2018 B2
20010000797 Mazzocchi May 2001 A1
20010001835 Greene et al. May 2001 A1
20020151883 Guqlielmi Oct 2002 A1
20030014073 Bashiri et al. Jan 2003 A1
20030018294 Cox Jan 2003 A1
20030028209 Teoh et al. Feb 2003 A1
20030040733 Craaa et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030060833 Carrison et al. Mar 2003 A1
20030176857 Lee Sep 2003 A1
20030212426 Olson Nov 2003 A1
20030225365 Greff et al. Dec 2003 A1
20040002731 Aqanon et al. Jan 2004 A1
20040225279 Ravmond Nov 2004 A1
20040236344 Monstadt et al. Nov 2004 A1
20050079196 Henkes et al. Apr 2005 A1
20050149108 Cox Jul 2005 A1
20050267511 Marks et al. Dec 2005 A1
20060036281 Patterson et al. Feb 2006 A1
20060100602 Klint May 2006 A1
20060135986 Wallace et al. Jun 2006 A1
20060155323 Porter et al. Jul 2006 A1
20060200234 Hines Sep 2006 A1
20060206199 Churchwell et al. Sep 2006 A1
20060271097 Ramzipoor et al. Nov 2006 A1
20070073334 Ramzipoor Mar 2007 A1
20070100426 Rudakov et al. May 2007 A1
20070175536 Monetti et al. Aug 2007 A1
20070191924 Rudakov Aug 2007 A1
20080045922 Craaa et al. Feb 2008 A1
20080051803 Monjtadt et al. Feb 2008 A1
20080103585 Monstadt et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080221666 Licata et al. Sep 2008 A1
20080228215 Strauss et al. Sep 2008 A1
20080228216 Strauss et al. Sep 2008 A1
20080319532 Monstadt et al. Dec 2008 A1
20090143786 Bashiri et al. Jun 2009 A1
20090227976 Calabria et al. Sep 2009 A1
20090254111 Monstadt et al. Oct 2009 A1
20100023105 Levv et al. Jan 2010 A1
20100030200 Strauss et al. Feb 2010 A1
20100049165 Sutherland et al. Feb 2010 A1
20100063572 Teoh et al. Mar 2010 A1
20100076479 Monstadt Mar 2010 A1
20100121350 Mirigian May 2010 A1
20100144895 Porter Jun 2010 A1
20100256666 Chen et al. Oct 2010 A1
20100268204 Tieu et al. Oct 2010 A1
20100331948 Turovskiy et al. Dec 2010 A1
20110098814 Monstadt et al. Apr 2011 A1
20110106128 Chen May 2011 A1
20110118768 Tran et al. May 2011 A1
20110118777 Patterson et al. May 2011 A1
20110137405 Wilson et al. Jun 2011 A1
20110184453 Levy et al. Jul 2011 A1
20120010648 Monstadt et al. Jan 2012 A1
20120209310 Chen et al. Aug 2012 A1
20120271344 Ford et al. Oct 2012 A1
20120316632 Gao Dec 2012 A1
20130138198 Aporta et al. May 2013 A1
20130184743 Chen et al. Jul 2013 A1
20130211492 Schneider et al. Aug 2013 A1
20130274866 Cox et al. Oct 2013 A1
20140005651 Eskridqe Jan 2014 A1
20140012307 Franano et al. Jan 2014 A1
20140039535 Eskuri Feb 2014 A1
20140058420 Hannes et al. Feb 2014 A1
20140135818 Gandhi et al. May 2014 A1
20140142608 Eskridge et al. May 2014 A1
20140148843 Strauss et al. May 2014 A1
20140163604 Monstadt Jun 2014 A1
20140236217 Gandhi et al. Aug 2014 A1
20140277092 Teoh et al. Sep 2014 A1
20140277094 Chen et al. Sep 2014 A1
20140288633 Burke et al. Sep 2014 A1
20140316012 Freyman et al. Oct 2014 A1
20140371734 Truckai Dec 2014 A1
20140371839 Henkes et al. Dec 2014 A1
20150005804 Franano et al. Jan 2015 A1
20150057700 Chen et al. Feb 2015 A1
20150066073 Ma Mar 2015 A1
20150105817 Marchand et al. Apr 2015 A1
20150133990 Davidson May 2015 A1
20150142042 Cox May 2015 A1
20150150563 Marchand et al. Jun 2015 A1
20150157331 Levy et al. Jun 2015 A1
20150164665 Cam et al. Jun 2015 A1
20150173771 Marks et al. Jun 2015 A1
20150216684 Enzmann et al. Aug 2015 A1
20150250628 Monstadt et al. Sep 2015 A1
20150313737 Tippett et al. Nov 2015 A1
20150327843 Garrison Nov 2015 A1
20160066921 Seifert et al. Mar 2016 A1
20160135984 Rudakov et al. May 2016 A1
20160206320 Connor Jul 2016 A1
20160206321 Connor Jul 2016 A1
20170035437 Sarge Feb 2017 A1
20170150971 Hines Jun 2017 A1
20170156903 Shobayashi Jun 2017 A1
20170189035 Porter Jul 2017 A1
20170266023 Thomas Sep 2017 A1
20170340333 Badruddin et al. Nov 2017 A1
20170367708 Mayer et al. Dec 2017 A1
20180049859 Stoppenhagen et al. Feb 2018 A1
20180125686 Lu May 2018 A1
20180140305 Connor May 2018 A1
20180161185 Kresslein et al. Jun 2018 A1
20180193025 Walzman Jul 2018 A1
20180193026 Yang et al. Jul 2018 A1
20180206852 Moeller Jul 2018 A1
20190053811 Garza et al. Feb 2019 A1
Foreign Referenced Citations (7)
Number Date Country
4445715 Jun 1996 DE
1884208 Feb 2008 EP
2668914 Dec 2013 EP
2011066962 Jun 2011 WO
WO-2014078286 May 2014 WO
2017074411 May 2017 WO
2018051187 Mar 2018 WO
Related Publications (1)
Number Date Country
20170367709 A1 Dec 2017 US
Provisional Applications (1)
Number Date Country
62355431 Jun 2016 US